Email UpdatesSan Francisco Department of Public Health Low Barrier Buprenorphine Pilot Program
These are slides from a 2019 presentation on the results of a low barrier buprenorphine pilot program conducted by the San Francisco Department of Public Health.
Prescribing Opioids
Promote the safe, effective use of prescription opioids
Academic Detailing Services - Opioid Overdose Education & Naloxone Distribution (OEND)
The VA Opioid Overdose Education & Naloxone Distribution (OEND) Program aims to reduce harm and risk of life-threatening opioid-related overdose and deaths among Veterans. This resource hub includes implementation toolkits, patient & provider guides, overdose education & naloxone distribution vidoes, and additional related VA resources.
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
This resource document provides practical, evidence-based information for primary care providers and practices on prescribing buprenorphine to individuals in need of intervention, including implementation considerations and strategies for primary care providers and primary care organizations.
Community Safety Topic - Opioids
This overview of opioids from the NSC includes information on opioid misuse, recognizing signs of an overdose, prescription painkillers and chronic pain, and more.
SAMHSA Training Requirements (MATE Act) Resources
This SAMHSA page includes information on 2023 training requirements that eliminated the DATA waiver that was previously needed to prescribe buprenorphine and expanded the number of DEA-registered practitioners able to treat people with opioid use disorder.
Evaluation of Mental Health Mobile Applications
This Technical Brief proposes a framework to assess mental health mobile applications, including those related to substance use, with the aim to facilitate selection of apps. The results of applying the framework will yield summary statements on the strengths and limitations of the apps and are intended for use by providers and patients/caregivers.
Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report
These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.
2022 National Drug Control Strategy
This inaugural National Strategy proposes bold, targeted, and consequential actions to bend the curve on overdose deaths in the immediate term and reduce substance use and its damaging consequences in the US over the longer term.
Treating Opioid Use Disorder During Pregnancy
This NIDA policy brief shares evidence-based research on treating opioud use dissorder on pregnancy, including the assessment of methadone and buprenorphine as treatment.
A Guideline for the Clinical Management of Opioid Use Disorder
This provincial evidence-based guideline articulates the full range of therapeutic options for the optimal treatment of adults and youth with varying presentations of opioid use disorder. It is intended for use for all British Colombia (BC) physicians, nursing and allied health professionals, and other care providers involved in the treatment of individuals with opioid use disorder.